Feature

Video

Sponsored

The Mission Behind CAR T-cell Clinical Trials

Author(s):

Robert Alaburda,Fabian Gerlinghaus

Panelists set up for addressing the clinical trial landscape, key challenges, regulations, and the future of cell and gene therapy.

In this exclusive Pharmaceutical Executive Roundtable video series, Robert Alaburda, Associate Editorial Director, talks with several experts about the building blocks for success in CAR T-cell clinical trials. The panelists introduce their expertise and background in clinical trials.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Peer Exchange: AI’s Data Advantage
July 31st 2025

Peer Exchange: AI’s Data Advantage

Mike Hollan
In the third part of this roundtable discussion, experts discuss the issues with data that AI must overcome.
Peer Exchange: Marketing With AI
July 31st 2025

Peer Exchange: Marketing With AI

Mike Hollan
In the second part of this roundtable discussion, experts discuss how the industry is handling AI in the marketing space.
AI Adoption
July 31st 2025

Peer Exchange: Embracing AI in Pharma

Mike Hollan
In this first part of this roundtable discussion, experts discuss the current perception of AI and how this is impacting adoption.
Today’s New Messaging Mix: The State of Pharma Marketing in 2024
July 31st 2025

Today’s New Messaging Mix: The State of Pharma Marketing in 2024

Mike Hollan
Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.
Roundtable: Current State of the Pharma Sales and Marketing Sales Force
July 31st 2025

Roundtable: Current State of the Pharma Sales and Marketing Sales Force

DOL KOL Roundtable
July 31st 2025

An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs

Mike Hollan
Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.